A Review on Melatonin’s Effects in Cancer: Potential Mechanisms

Author(s): Aysegul Hanikoglu, Ertan Kucuksayan, Rana Cagla Akduman, Tomris Ozben*

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 18 , Issue 7 , 2018

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


This systematic review aims to elucidate the role of melatonin (N-acetyl-5-metoxy-tryptamine) (MLT) in the prevention and treatment of cancer. MLT is a pineal gland secretory product, an evolutionarily highly conserved molecule; it is also an antioxidant and an impressive protector of mitochondrial bioenergetic activity. MLT is characterized by an ample range of activities, modulating the physiology and molecular biology of the cell. Its physiological functions relate principally to the interaction of G Protein-Coupled MT1 and MT2 trans-membrane receptors (GPCRs), a family of guanidine triphosphate binding proteins. MLT has been demonstrated to suppress the growth of various tumours both, in vivo and in vitro. In this review, we analyze in depth, the antioxidant activity of melatonin, aiming to illustrate the cancer treatment potential of the molecule, by limiting or reversing the changes occurring during cancer development and growth.

Keywords: Melatonin, cancer prevention, molecular biology, oxidative stress, antioxidant, cell culture.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 30 November, 2018
Page: [985 - 992]
Pages: 8
DOI: 10.2174/1871520617666171121120223
Price: $65

Article Metrics

PDF: 32